ladostigil hemitartrate
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2011 (NCT01354691)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ladostigil hemitartrate
- ladostigil hemitartrate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01429623 | Phase 2 | Feb 1, 2012 | Avraham Pharmaceuticals Ltd |
| NCT01354691 | Phase 2 | Feb 1, 2011 | Avraham Pharmaceuticals Ltd, Medical University of Graz |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Avraham Pharmaceuticals Ltd | For profit | 2 | 2 | 1 | 2011 |
| Medical University of Graz | Academic/Hospital | 1 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1